Prevalence and risk factors of mcr-1-positive volunteers after colistin banning as animal growth promoter in China: a community-based case–control study. (February 2022)
- Record Type:
- Journal Article
- Title:
- Prevalence and risk factors of mcr-1-positive volunteers after colistin banning as animal growth promoter in China: a community-based case–control study. (February 2022)
- Main Title:
- Prevalence and risk factors of mcr-1-positive volunteers after colistin banning as animal growth promoter in China: a community-based case–control study
- Authors:
- Lv, Ziquan
Shen, Yingbo
Liu, Weiwen
Ye, Hailing
Liu, Dejun
Liu, Juan
Fu, Yulin
Peng, Changfeng
Chen, Kun
Deng, Xiangxiao
Liu, Bang
He, Jie
Yang, Lu
Xu, Chunyan
Cai, Chang
Wang, Yang
Ke, Yuebin
Shen, Jianzhong - Abstract:
- Abstract: Objectives: China banned the use of colistin as animal growth promoter in April 2017. Herein, we report the prevalence of mcr-1 in the intestine of healthy humans and risk factors associated with mcr-1 carriage after the implementation of the ban. Methods: We recruited 719 healthy volunteers from Shenzhen City from 1 March 2018 to 31 December 2019 to investigate the prevalence of mcr-1 in human intestine, and undertook a case–control study to ascertain the risk factors associated with the mcr-1 -positive population. A further comparative study was conducted to identify differences between genetic characteristics of mcr-1 -positive and mcr-1 -negative Escherichia coli . Results: Overall, 56 (7.8%, 95% CI 5.9%–10.0%, n = 719) individual faecal samples were positive for mcr-1, and prevalence of mcr-1 among individuals in 2019 (2.4%, 95% CI 8.7%–15.0%, 7/294) was significantly lower than that in 2018 (11.5%, 95% CI 1.0%–4.8%, 49/425) (p < 0.0001). After the colistin ban, animal-derived food (pork and chicken meat) was no longer a risk factor for mcr-1 carriage in human intestine, whereas a higher intake of fish and seafood (>75 g/day) and whole grains (>150 g/day) was associated with higher and lower risk of mcr-1 carriage, respectively (OR 2.175, 95% CI 1.047–4.517; OR 0.045, 95% CI 0.004–0.567). Compared with mcr-1 -negative E. coli, the mcr-1 -positive E. coli had different patterns of resistance genes and genetic heterogeneity. Conclusions: Our study implicatesAbstract: Objectives: China banned the use of colistin as animal growth promoter in April 2017. Herein, we report the prevalence of mcr-1 in the intestine of healthy humans and risk factors associated with mcr-1 carriage after the implementation of the ban. Methods: We recruited 719 healthy volunteers from Shenzhen City from 1 March 2018 to 31 December 2019 to investigate the prevalence of mcr-1 in human intestine, and undertook a case–control study to ascertain the risk factors associated with the mcr-1 -positive population. A further comparative study was conducted to identify differences between genetic characteristics of mcr-1 -positive and mcr-1 -negative Escherichia coli . Results: Overall, 56 (7.8%, 95% CI 5.9%–10.0%, n = 719) individual faecal samples were positive for mcr-1, and prevalence of mcr-1 among individuals in 2019 (2.4%, 95% CI 8.7%–15.0%, 7/294) was significantly lower than that in 2018 (11.5%, 95% CI 1.0%–4.8%, 49/425) (p < 0.0001). After the colistin ban, animal-derived food (pork and chicken meat) was no longer a risk factor for mcr-1 carriage in human intestine, whereas a higher intake of fish and seafood (>75 g/day) and whole grains (>150 g/day) was associated with higher and lower risk of mcr-1 carriage, respectively (OR 2.175, 95% CI 1.047–4.517; OR 0.045, 95% CI 0.004–0.567). Compared with mcr-1 -negative E. coli, the mcr-1 -positive E. coli had different patterns of resistance genes and genetic heterogeneity. Conclusions: Our study implicates aquatic food as beeing associated with mcr-1 carriage in the healthy population, even after the ban on colistin. Dietary modification (e.g. whole grains) may help to combat mcr-1 -positive bacterial colonization of the gut. … (more)
- Is Part Of:
- Clinical microbiology and infection. Volume 28:Number 2(2022)
- Journal:
- Clinical microbiology and infection
- Issue:
- Volume 28:Number 2(2022)
- Issue Display:
- Volume 28, Issue 2 (2022)
- Year:
- 2022
- Volume:
- 28
- Issue:
- 2
- Issue Sort Value:
- 2022-0028-0002-0000
- Page Start:
- 267
- Page End:
- 272
- Publication Date:
- 2022-02
- Subjects:
- Colistin -- Escherichia coli -- Healthy human -- mcr-1 -- Risk factors
Medical microbiology -- Periodicals
Diagnostic microbiology -- Periodicals
Communicable diseases -- Periodicals
Infection -- Periodicals
616.01 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1469-0691 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1016/j.cmi.2021.06.033 ↗
- Languages:
- English
- ISSNs:
- 1198-743X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.305520
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 20631.xml